Are ASX 200 value shares still good value? Why these experts are at loggerheads

ASX 200 growth shares or ASX 200 value shares? Investors looking towards the next stage of the pandemic recovery may need to reposition.

The comeback of the S&P/ASX 200 Index (ASX: XJO) from the record breaking COVID-19 market meltdown last February and March has been nothing short of stellar.

Since the March 2020 lows, the ASX 200 has soared 42%. If you've never witnessed anything like it, don't worry. No one has.

close up of man's eye looking through magnifying glass representing asx 200 share price on watch

Image source: Getty Images

ASX 200 shares sprinted to record gains

While most shares gained strongly during the rebound, it was the ASX 200 growth shares that led the charge. Think of companies like ASX buy now, pay later (BNPL) darling, and Afterpay Ltd (ASX: APT).

Although down 34% since its 10 February 2021 highs, the Afterpay share price is still up 740% since 20 March 2020.

Other ASX 200 shares have underperformed the index and far underperformed growth shares like Afterpay.

With international and even most domestic air travel locked down for much of the past 12 months, the Sydney Airport Holdings Pty Ltd (ASX: SYD) share price has only gained 28% since 20 March 2020. While that may not sound like a small gain (and it's not), the Sydney Airport share price is still down 32% since 27 December 2019.

With these kinds of figures in mind, investors are increasingly wondering about the outlook for value shares.

For that answer, we turn to the experts.

Why these investment experts disagree on the outlook for value shares

If you were hoping for a unified answer, those months appear behind us.

As Bloomberg reports:

Societe Generale SA and JPMorgan Chase & Co. say value shares will keep outperforming at this stage of the market cycle. Prudential Financial Inc. and AlphaOmega Advisors LLC say the sector is due for a pullback.

Solomon Tadesse is Societe Generale's head of North American equity quant research in New York. According to Tadesse:

Value (and more generally cyclicals) still command significant valuation advantage to the rest of the market. Distressed out-of-favour assets tend to gain from potential multiple expansion at this point of the market cycle.

And JPMorgan Chase strategists led by Dubravko Lakos-Bujas write that:

Value remains an outsized beneficiary of reopening, which is still in its early stages… [W]hile we believe value and reopening trade still has room for upside, we would emphasize focusing on higher quality companies with greater staying power, for example retail and energy.

On the other side of the value share debate is Peter Cecchini, founder and chief strategist of AlphaOmega Advisors. According to Cecchini:

It's time to take money off the table now. Perhaps the latest round of stimulus will keep the cyclicals trade alive a bit longer, but I just don't see the cycle turning for good as we might expect after a normal recession. Staying tactical and nimble seems prudent.

As for Prudential Financial, as Bloomberg reports, Quincy Krosby, chief market strategist says, "The reflation trade is 'frothy' and 'waiting for a pullback is prudent'."

Krosby believes investors have been too optimistic about the massive new infrastructure cash splash proposed by United States President Joe Biden. She said that if investors sense issues within Congress that could delay or derail the package, shares could sell-off. Which, she says, could be the right time to buy the dip.

Foolish takeaway

So what's an ASX 200 investor to do?

I believe Peter Cecchini, quoted above, has it right. "Staying tactical and nimble seems prudent."

Happy investing.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

A little girl wearing wonky glasses checks out what's happening in the world on a mobile phone.
Broker Notes

Buy, hold, sell: Paladin Energy, Accent, Sigma Healthcare shares

Experts reveal the reasons behind their new ratings.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Opinions

3 reasons why I think this leading ASX 200 share is a buy

This underrated business could be a top buy today…

Read more »

Man in shirt and tie falls face first down stairs.
Record Lows

I think this ASX 200 stock looks like a bargain after hitting an all-time low: Here's why

The ASX shares fell another 8% on Tuesday.

Read more »

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

Man working on a laptop from home.
ASX Share Market News

5 things to watch on the ASX 200 on Wednesday

It could be another tough session for Aussie investors on hump day.

Read more »

A woman sprints with a trail of fire blazing from her body.
Opinions

I hunted the ASX for shares with the potential to double. This one stood out

Do you have this ASX share in your investment portfolio?

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Opinions

I wanted growth, not hype. Only 3 ASX shares passed my checks

One of these ASX shares is tipped to climb up to 38%.

Read more »